Physician profile
May Lee
NPI 1174237127
$1,257.75
in general payments reported to CMS, 2019-2025
16 companies · $552 in 2025
The $552 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $79.96 · 2024: $625 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Education: $17.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.87 |
| Education | $17.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $159.01 | 2025 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $154.01 | 2025 | Jynarque |
| Travere Therapeutics, INC. | $145.23 | 2024 | |
| Ardelyx, INC. | $144.69 | 2024-2025 | Xphozah 30 Mg, Ibsrela |
| Aurinia Pharma U.S., INC. | $125.10 | 2024 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.66 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $63.51 | 2025 | |
| Abbott Laboratories | $60.00 | 2023 | Aveir |
| Lilly USA, LLC | $57.83 | 2024 | Jardiance |
| Calliditas Therapeutics US INC. | $55.10 | 2024-2025 | Tarpeyo |
| Ani Pharmaceuticals, INC. | $49.35 | 2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $36.75 | 2025 | |
| Boston Scientific Corporation | $36.04 | 2025 | Jetstream Sc |
| Amgen INC. | $20.63 | 2024 | Krystexxa |
| Hologic Sales and Service, LLC | $19.96 | 2023 | Novasure, Myosure Tissue Removal Device |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $17.88 | 2024 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.